294 related articles for article (PubMed ID: 19671858)
1. Epigenetic deregulation of DNA repair and its potential for therapy.
Hegi ME; Sciuscio D; Murat A; Levivier M; Stupp R
Clin Cancer Res; 2009 Aug; 15(16):5026-31. PubMed ID: 19671858
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic gene regulation in cancer.
Ballestar E; Esteller M
Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the epigenetic code of cancer for therapy.
Smith LT; Otterson GA; Plass C
Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396
[TBL] [Abstract][Full Text] [Related]
4. [Value of inhibition of signal transduction and epigenetic therapy concepts in cancer therapy].
Tabernero J; Kaye S
Onkologie; 2005 Oct; 28 Suppl 4():43-7. PubMed ID: 16285040
[No Abstract] [Full Text] [Related]
5. Epigenetic alterations and cancer: new targets for therapy.
Allen A
IDrugs; 2007 Oct; 10(10):709-12. PubMed ID: 17899489
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic opportunities and challenges in cancer.
Best JD; Carey N
Drug Discov Today; 2010 Jan; 15(1-2):65-70. PubMed ID: 19897050
[TBL] [Abstract][Full Text] [Related]
7. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
Kinsella TJ
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic biomarkers for human cancer: the time is now.
Mulero-Navarro S; Esteller M
Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
[TBL] [Abstract][Full Text] [Related]
9. Cancer epigenomics: implications of DNA methylation in personalized cancer therapy.
Toyota M; Suzuki H; Yamashita T; Hirata K; Imai K; Tokino T; Shinomura Y
Cancer Sci; 2009 May; 100(5):787-91. PubMed ID: 19236379
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors.
Duenas-Gonzalez A; Candelaria M; Perez-Plascencia C; Perez-Cardenas E; de la Cruz-Hernandez E; Herrera LA
Cancer Treat Rev; 2008 May; 34(3):206-22. PubMed ID: 18226465
[TBL] [Abstract][Full Text] [Related]
11. DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes.
Kennedy RD; D'Andrea AD
J Clin Oncol; 2006 Aug; 24(23):3799-808. PubMed ID: 16896009
[TBL] [Abstract][Full Text] [Related]
12. Emerging molecular therapies of advanced thyroid cancer.
Catalano MG; Poli R; Pugliese M; Fortunati N; Boccuzzi G
Mol Aspects Med; 2010 Apr; 31(2):215-26. PubMed ID: 20176050
[TBL] [Abstract][Full Text] [Related]
13. Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.
Zhu Y; Hu J; Hu Y; Liu W
Cancer Treat Rev; 2009 Nov; 35(7):590-6. PubMed ID: 19635647
[TBL] [Abstract][Full Text] [Related]
14. Targeting homologous recombination repair defects in cancer.
Evers B; Helleday T; Jonkers J
Trends Pharmacol Sci; 2010 Aug; 31(8):372-80. PubMed ID: 20598756
[TBL] [Abstract][Full Text] [Related]
15. Non-mammalian models for epigenetic analyses in cancer.
Schaefer M; Meusburger M; Lyko F
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R1-6. PubMed ID: 17613542
[TBL] [Abstract][Full Text] [Related]
16. Molecular-targeted therapies: lessons from years of clinical development.
Rosa DD; Ismael G; Lago LD; Awada A
Cancer Treat Rev; 2008 Feb; 34(1):61-80. PubMed ID: 17826917
[TBL] [Abstract][Full Text] [Related]
17. Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches.
Dietlein F; Thelen L; Reinhardt HC
Trends Genet; 2014 Aug; 30(8):326-39. PubMed ID: 25017190
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic therapies reach main street.
Bates SE
Clin Cancer Res; 2009 Jun; 15(12):3917. PubMed ID: 19528089
[No Abstract] [Full Text] [Related]
19. DNA repair: a reinvigorated therapeutic target.
Bates SE
Clin Cancer Res; 2010 Sep; 16(18):4510. PubMed ID: 20823139
[No Abstract] [Full Text] [Related]
20. Epigenetic changes in cancer as potential targets for prophylaxis and maintenance therapy.
Grønbaek K; Treppendahl M; Asmar F; Guldberg P
Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):389-96. PubMed ID: 18947362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
